$GNSS
Genasys Inc. Stock $gnss

$gnss Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-K Financial Statement

#000143774922029275 Filed on December 16, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2022
Revenue	$10.49M	$16.04M	$54.04M
YoY Change	-1.78%	6.59%	14.96%
Cost Of Revenue	$5.944M	$8.378M	$27.69M
YoY Change	2.78%	14.02%	17.46%
Gross Profit	$4.543M	$7.660M	$26.34M
YoY Change	-7.17%	-0.51%	12.45%
Gross Profit Margin	43.32%	47.76%	48.75%
Selling, General & Admin	$6.095M	$5.568M	$21.69M
YoY Change	18.72%	2.11%	24.47%
% of Gross Profit	134.16%	72.69%	82.33%
Research & Development	$1.935M	$1.696M	$7.023M
YoY Change	41.34%	12.92%	42.8%
% of Gross Profit	42.59%	22.14%	26.66%
Depreciation & Amortization	$643.0K	$636.0K	$2.556M
YoY Change	0.63%	-1.24%	60.05%
% of Gross Profit	14.15%	8.3%	9.7%
Operating Expenses	$8.030M	$7.264M	$28.71M
YoY Change	23.48%	4.44%	28.51%
Operating Profit	-$3.487M	$396.0K	-$2.369M
YoY Change	116.72%	-46.77%	-318.54%
Interest Expense		$6.000K	$6.000K
YoY Change		-92.11%	-92.11%
% of Operating Profit		1.52%
Other Income/Expense, Net	-$20.00K	$48.00K	$60.00K
YoY Change	-253.85%	-159.26%	11.11%
Pretax Income	-$3.507M	-$12.72M	-$15.47M
YoY Change	119.74%	-1919.46%	-1459.49%
Income Tax	$0.00	$1.108M	$741.0K
% Of Pretax Income
Net Earnings	-$3.507M	-$13.83M	-$16.21M
YoY Change	168.74%	-1893.26%	-2402.84%
Net Earnings / Revenue	-33.44%	-86.21%	-30.0%
Basic Earnings Per Share	-$0.10		-$0.44
Diluted Earnings Per Share	-$0.10	-$377.8K	-$444.2K
COMMON SHARES
Basic Shares Outstanding	36.70M	36.60M	36.50M
Diluted Shares Outstanding	36.70M		36.50M

Balance Sheet

Concept	2022 Q4	2022 Q3	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$7.563M	$19.13M	$19.13M
YoY Change	-42.56%	45.31%	1.49%
Cash & Equivalents	$7.563M	$12.74M	$12.74M
Short-Term Investments	$0.00	$6.397M	$6.397M
Other Short-Term Assets	$184.0K	$3.677M	$3.677M
YoY Change	44.88%	1067.3%	45.11%
Inventory	$8.003M	$6.008M	$6.008M
Prepaid Expenses
Receivables	$3.297M	$6.744M	$6.744M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$29.09M	$35.56M	$35.56M
YoY Change	-7.65%	0.22%	0.22%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.755M	$6.298M	$6.298M
YoY Change	-3.62%	258.86%	-4.82%
Goodwill	$10.31M	$10.12M
YoY Change	-56.67%	-57.55%
Intangibles	$10.00M	$10.51M
YoY Change	-18.34%	-17.96%
Long-Term Investments	$1.034M	$781.0K	$781.0K
YoY Change	-69.42%	-58.35%	-58.35%
Other Assets	$7.891M	$8.590M	$8.590M
YoY Change	-19.9%	-9.7%	-9.7%
Total Long-Term Assets	$35.38M	$36.29M	$36.29M
YoY Change	-36.58%	-33.58%	-33.58%
TOTAL ASSETS
Total Short-Term Assets	$29.09M	$35.56M	$35.56M
Total Long-Term Assets	$35.38M	$36.29M	$36.29M
Total Assets	$64.46M	$71.85M	$71.85M
YoY Change	-26.14%	-20.28%	-20.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.609M	$2.334M	$2.334M
YoY Change	15.49%	8.06%	8.06%
Accrued Expenses	$8.075M	$13.03M	$13.03M
YoY Change	-35.97%	-7.65%	151.22%
Deferred Revenue	$4.596M	$6.551M
YoY Change	-52.45%	-33.3%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Total Short-Term Liabilities	$11.64M	$15.37M	$15.37M
YoY Change	-27.56%	-12.03%	-12.03%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$243.0K	$6.096M	$6.096M
YoY Change	-75.58%	512.66%	-9.07%
Total Long-Term Liabilities	$243.0K	$6.096M	$6.096M
YoY Change	-75.58%	512.66%	-9.07%
TOTAL LIABILITIES
Total Short-Term Liabilities	$11.64M	$15.37M	$15.37M
Total Long-Term Liabilities	$243.0K	$6.096M	$6.096M
Total Liabilities	$16.86M	$21.46M	$21.46M
YoY Change	-25.23%	-11.21%	-11.21%
SHAREHOLDERS EQUITY
Retained Earnings	-$60.87M	-$57.37M
YoY Change	43.37%	39.39%
Common Stock	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$47.60M	$50.39M	$50.39M
YoY Change
Total Liabilities & Shareholders Equity	$64.46M	$71.85M	$71.85M
YoY Change	-26.14%	-20.28%	-20.28%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2022
OPERATING ACTIVITIES
Net Income	-$3.507M	-$13.83M	-$16.21M
YoY Change	168.74%	-1893.26%	-2402.84%
Depreciation, Depletion And Amortization	$643.0K	$636.0K	$2.556M
YoY Change	0.63%	-1.24%	60.05%
Cash From Operating Activities	-$4.850M	$1.039M	$468.0K
YoY Change	79.5%	-148.01%	-92.39%
INVESTING ACTIVITIES
Capital Expenditures	$98.00K	-$190.0K	$381.0K
YoY Change	-38.36%	603.7%	83.17%
Acquisitions	$0.00		$0.00
YoY Change			-100.0%
Other Investing Activities	-$385.0K	$87.00K	$292.0K
YoY Change	-266.67%	-87.75%	-101.9%
Cash From Investing Activities	-$483.0K	-$103.0K	-$89.00K
YoY Change	-770.83%	-115.08%	-99.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net			$277.0K
YoY Change			1357.89%
Cash From Financing Activities	$32.00K	29.00K	-$1.063M
YoY Change	-108.1%	-27.5%	-8276.92%
NET CHANGE
Cash From Operating Activities	-$4.850M	1.039M	$468.0K
Cash From Investing Activities	-$483.0K	-103.0K	-$89.00K
Cash From Financing Activities	$32.00K	29.00K	-$1.063M
Net Change In Cash	-$5.262M	965.0K	-$869.0K
YoY Change	73.32%	-166.97%	-90.82%
FREE CASH FLOW
Cash From Operating Activities	-$4.850M	$1.039M	$468.0K
Capital Expenditures	$98.00K	-$190.0K	$381.0K
Free Cash Flow	-$4.948M	$1.229M	$87.00K
YoY Change	72.95%	-157.51%	-98.54%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2021Q3	gnss	Deferred Revenue For Collection Issues DeferredRevenueForCollectionIssues	0	usd
CY2022Q3	gnss	Deferred Revenue For Collection Issues DeferredRevenueForCollectionIssues	0	usd
CY2022	gnss	Investments Typical Final Maturity InvestmentsTypicalFinalMaturity	P3Y
CY2022Q3	gnss	Number Of Additional Inactive Subsidiaries NumberOfAdditionalInactiveSubsidiaries	2	pure
CY2022Q3	gnss	Number Of Wholly Owned Subsidiaries NumberOfWhollyOwnedSubsidiaries	8	pure
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	2334000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-253000	usd
CY2022Q3	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-704000	usd
CY2022	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2021Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0000924383
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	gnss	Number Of Major Customers NumberOfMajorCustomers	2	pure
CY2022	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
CY2021Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021	us-gaap	Dividends Dividends	0	usd
CY2022	us-gaap	Dividends Dividends	0	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P7Y
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	0	usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	0	usd
CY2021Q3	us-gaap	Marketable Securities MarketableSecurities	0	usd
CY2022Q3	us-gaap	Marketable Securities MarketableSecurities	0	usd
CY2021Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	0-24248
CY2022	dei	Entity Registrant Name EntityRegistrantName	GENASYS INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-0361799
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	16262 West Bernardo Drive,
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	San Diego
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92127
CY2022	dei	City Area Code CityAreaCode	858
CY2022	dei	Local Phone Number LocalPhoneNumber	676-1112
CY2022	dei	Security12b Title Security12bTitle	Common stock, $0.00001 par value per share
CY2022	dei	Trading Symbol TradingSymbol	GNSS
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2021Q1	dei	Entity Public Float EntityPublicFloat	191676200	usd
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	36703471
CY2022	dei	Auditor Firm AuditorFirmId	23
CY2022	dei	Auditor Name AuditorName	BAKER TILLY US, LLP
CY2022	dei	Auditor Location AuditorLocation	San Diego, California
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	12083000	usd
CY2022Q3	us-gaap	Notes Payable Current NotesPayableCurrent	0	usd
CY2021Q3	us-gaap	Notes Payable Current NotesPayableCurrent	296000	usd
CY2021Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	899000	usd
CY2021Q3	us-gaap	Liabilities Current LiabilitiesCurrent	17466000	usd
CY2021Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	995000	usd
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5709000	usd
CY2021Q3	us-gaap	Liabilities Liabilities	24170000	usd
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2022Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2021Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	36611240
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36611240
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36403833
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	36403833
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	0	usd
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	0	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	108551000	usd
CY2021Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	107110000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-57366000	usd
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-41154000	usd
CY2022Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-792000	usd
CY2021Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	50393000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	65958000	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	71854000	usd
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	90128000	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	54035000	usd
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	47003000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	27693000	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	23577000	usd
CY2022	us-gaap	Gross Profit GrossProfit	26342000	usd
CY2021	us-gaap	Gross Profit GrossProfit	23426000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	21688000	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	17424000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7023000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4918000	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	13162000	usd
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	41873000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	22342000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-15531000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	1084000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	60000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	54000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1138000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-16212000	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.44
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.44
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36495012
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34409478
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	36495012
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	35589148
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-16212000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	704000	usd
CY2022	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-90000	usd
CY2021	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-8000	usd
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	49140000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1424000	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	210000	usd
CY2021	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	141000	usd
CY2021	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	10938000	usd
CY2021	gnss	Adjustments To Additional Paid In Capital Stock Obligation To Issue Acquisition AdjustmentsToAdditionalPaidInCapitalStockObligationToIssueAcquisition	3431000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	252000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	704000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	65958000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2227000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	282000	usd
CY2022	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	70000	usd
CY2022	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	998000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-794000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-16212000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	50393000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-16212000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	704000	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	13162000	usd
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2556000	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1597000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	19000	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	11000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	55000	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2022	gnss	Product Warranty Expense Benefit ProductWarrantyExpenseBenefit	86000	usd
CY2021	gnss	Product Warranty Expense Benefit ProductWarrantyExpenseBenefit	54000	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	333000	usd
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	379000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	2227000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	1424000	usd
CY2022	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-0	usd
CY2021	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	76000	usd
CY2022	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	666000	usd
CY2021	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	433000	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	746000	usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	694000	usd
CY2022	us-gaap	Accretion Expense AccretionExpense	48000	usd
CY2021	us-gaap	Accretion Expense AccretionExpense	46000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-836000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2138000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-75000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	846000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-242000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	199000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	600000	usd
CY2022	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-4570000	usd
CY2021	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	4902000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	468000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6150000	usd
CY2022	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	6830000	usd
CY2021	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	5144000	usd
CY2022	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	7122000	usd
CY2021	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	5646000	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-0	usd
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	15848000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	381000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	208000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-89000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-15554000	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	282000	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	210000	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	998000	usd
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	-0	usd
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	70000	usd
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	141000	usd
CY2022	us-gaap	Repayments Of Unsecured Debt RepaymentsOfUnsecuredDebt	277000	usd
CY2021	us-gaap	Repayments Of Unsecured Debt RepaymentsOfUnsecuredDebt	18000	usd
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	-0	usd
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	38000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1063000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	13000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-185000	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-77000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-869000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-9468000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	14528000	usd
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	23996000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	13659000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	14528000	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12736000	usd
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13167000	usd
CY2022Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	100000	usd
CY2021Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	279000	usd
CY2022Q3	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	823000	usd
CY2021Q3	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1082000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	13659000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	14528000	usd
CY2022	gnss	Noncash Or Part Noncash Unrealized Loss On Marketable Securities NoncashOrPartNoncashUnrealizedLossOnMarketableSecurities	-90000	usd
CY2021	gnss	Noncash Or Part Noncash Unrealized Loss On Marketable Securities NoncashOrPartNoncashUnrealizedLossOnMarketableSecurities	-7000	usd
CY2022	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	-0	usd
CY2021	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	10938000	usd
CY2022	gnss	Business Combination Consideration Transferred Equity Interests Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuable	832000	usd
CY2021	gnss	Business Combination Consideration Transferred Equity Interests Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuable	1248000	usd
CY2022	gnss	Initial Measurement Of Operating Lease Right Of Use Assets InitialMeasurementOfOperatingLeaseRightOfUseAssets	466000	usd
CY2021	gnss	Initial Measurement Of Operating Lease Right Of Use Assets InitialMeasurementOfOperatingLeaseRightOfUseAssets	259000	usd
CY2022	gnss	Initial Measurement Of Operating Lease Liabilities InitialMeasurementOfOperatingLeaseLiabilities	466000	usd
CY2021	gnss	Initial Measurement Of Operating Lease Liabilities InitialMeasurementOfOperatingLeaseLiabilities	259000	usd
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	0	usd
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	30980000	usd
CY2022	us-gaap	Nature Of Operations NatureOfOperations	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>1. OPERATIONS </b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:25pt;">Genasys Inc. is a global provider of critical communications hardware and software solutions designed to alert, inform, and protect people. The Company's unified platform receives information from a wide variety of sensors and Internet-of-Things (IoT) inputs to collect real-time information on developing and active emergency situations. The Company uses this information to create and disseminate alerts, warnings, notifications, and instructions through multiple channels before, during, and after public safety and enterprise threats, critical events, and other crisis situations.</p>
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<b>USE OF ESTIMATES </b>The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions (e.g., share-based compensation valuation, allowance for doubtful accounts, valuation of inventory, intangible assets and goodwill, warranty reserve, valuation of operating lease right of use assets and operating lease liabilities, accrued bonus and valuation allowance related to deferred tax assets) that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the financial statements and affect the reported amounts of revenues and expenses during the reporting periods. Actual results could materially differ from those estimates.
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<b>CONCENTRATION OF CREDIT RISK </b>The Company sells its products to a large number of geographically diverse customers. The Company routinely assesses the financial strength of its customers. It is customary for the Company to require a deposit as collateral. As of September 30, 2022, accounts receivable from <span style="-sec-ix-hidden:c417">two</span> customers accounted for 43% and 19% of total accounts receivable with no other single customer accounting for more than 10% of the accounts receivable balance. As of September 30, 2021, accounts receivable from two customers accounted for 66% and 18% of total accounts receivable with no other single customer accounting for more than 10% of the accounts receivable balance.The Company maintains cash and cash equivalent bank deposit accounts which, at times, may exceed federally insured limits guaranteed by the Federal Deposit Insurance Corporation (“FDIC”). The Company has not experienced any losses in such accounts. The Company limits its exposure to credit loss by depositing its cash with high credit quality financial institutions. The Company also invests cash in instruments that meet high credit quality standards, as specified in the Company’s policy guidelines such as money market funds, corporate bonds, municipal bonds and Certificates of Deposit. These guidelines also limit the amount of credit exposure to any one issue, issuer or type of instrument. It is generally the Company’s policy to invest in instruments that have a final maturity of no longer than <span style="-sec-ix-hidden:c422">three</span> years, with a portfolio weighted average maturity of no longer than 18 months.
CY2022	gnss	Investments Typical Portfolio Weighted Average Maturity InvestmentsTypicalPortfolioWeightedAverageMaturity	P18M
CY2022Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	5277000	usd
CY2021Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	5449000	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12736000	usd
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13167000	usd
CY2022Q3	us-gaap	Restricted Cash RestrictedCash	923000	usd
CY2021Q3	us-gaap	Restricted Cash RestrictedCash	1361000	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	181000	usd
CY2021Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	127000	usd
CY2022	gnss	Inventory Obsolescence Write Down Recoveries InventoryObsolescenceWriteDownRecoveries	-105000	usd
CY2022Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	844000	usd
CY2021Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	842000	usd
CY2022Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	744000	usd
CY2021Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	877000	usd
CY2022Q3	us-gaap	Inventory Gross InventoryGross	6865000	usd
CY2021Q3	us-gaap	Inventory Gross InventoryGross	7168000	usd
CY2022Q3	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.97	pure
CY2022	us-gaap	Advertising Expense AdvertisingExpense	677000	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	193000	usd
CY2022Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	159000	usd
CY2021Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	146000	usd
CY2022	us-gaap	Property Plant And Equipment Impairment PropertyPlantAndEquipmentImpairment	<b>IMPAIRMENT OF LONG-LIVED ASSETS </b>Long-lived assets and finite-lived intangibles held for use are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. If the carrying value of an intangible asset exceeds the fair value, or if changes in facts and circumstances indicate impairment, an impairment loss is measured and recognized using the asset’s fair value. There was <span style="-sec-ix-hidden:c445"><span style="-sec-ix-hidden:c447">no</span></span> impairment of long-lived assets for the years ended September 30, 2022 and September 30, 2021. Refer to Note 5, Fair Value Measurements and Note 8, Goodwill and Intangible Assets for additional information.
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	260000	usd
CY2022	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<b>RECLASSIFICATIONS </b>Where necessary, the prior year’s information has been reclassified to conform to the fiscal year 2022 statement presentation. These reclassifications had no effect on previously reported results of operations or accumulated deficit.
CY2022Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	857000	usd
CY2021Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	752000	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	6008000	usd
CY2021Q3	us-gaap	Inventory Net InventoryNet	6416000	usd
CY2021Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	10129000	usd
CY2022	gnss	Contract With Customer Liability Increase For New Contract ContractWithCustomerLiabilityIncreaseForNewContract	17226000	usd
CY2022	gnss	Contract With Customer Liability Revenue Recognized During Period ContractWithCustomerLiabilityRevenueRecognizedDuringPeriod	20550000	usd
CY2022	gnss	Contract With Customer Liability Effect Of Exchange Rate ContractWithCustomerLiabilityEffectOfExchangeRate	27000	usd
CY2022Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	6778000	usd
CY2022Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	227000	usd
CY2022Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	6551000	usd
CY2022Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	6778000	usd
CY2022Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	6551000	usd
CY2022Q3	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2022Q3	us-gaap	Nonfinancial Liabilities Fair Value Disclosure NonfinancialLiabilitiesFairValueDisclosure	680000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5099000	usd
CY2021Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4685000	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3342000	usd
CY2021Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2930000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1757000	usd
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1755000	usd
CY2022	us-gaap	Depreciation Depreciation	403000	usd
CY2021	us-gaap	Depreciation Depreciation	406000	usd
CY2022Q3	us-gaap	Goodwill Gross GoodwillGross	10118000	usd
CY2021Q3	us-gaap	Goodwill Gross GoodwillGross	23834000	usd
CY2021Q3	us-gaap	Goodwill Goodwill	23834000	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	13162000	usd
CY2022	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-554000	usd
CY2022Q3	us-gaap	Goodwill Goodwill	10118000	usd
CY2021Q3	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	82000	usd
CY2022Q3	gnss	Prepaid Trade Shows And Travel PrepaidTradeShowsAndTravel	471000	usd
CY2021Q3	gnss	Prepaid Trade Shows And Travel PrepaidTradeShowsAndTravel	95000	usd
CY2022Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	1631000	usd
CY2021Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	0	usd
CY2022Q3	us-gaap	Other Assets Current OtherAssetsCurrent	244000	usd
CY2021Q3	us-gaap	Other Assets Current OtherAssetsCurrent	315000	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	3577000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	14469000	usd
CY2021Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	14861000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3964000	usd
CY2021Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2057000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10505000	usd
CY2021Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	12804000	usd
CY2021Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	12804000	usd
CY2022	us-gaap	Finite Lived Intangible Assets Foreign Currency Translation Gain Loss FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss	-145000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10505000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2154000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1191000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2094000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2083000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1974000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1843000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1669000	usd
CY2022Q3	gnss	Finitelived Intangible Asset Expected Amortization After Year Four FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour	842000	usd
CY2022Q3	gnss	Finite Lived Intangible Assets Amortization Expense Total FiniteLivedIntangibleAssetsAmortizationExpenseTotal	10505000	usd
CY2022Q3	gnss	Deposits For Inventory DepositsForInventory	461000	usd
CY2021Q3	gnss	Deposits For Inventory DepositsForInventory	997000	usd
CY2022Q3	us-gaap	Prepaid Insurance PrepaidInsurance	360000	usd
CY2021Q3	us-gaap	Prepaid Insurance PrepaidInsurance	395000	usd
CY2022Q3	gnss	Due And Subscription DueAndSubscription	182000	usd
CY2021Q3	gnss	Due And Subscription DueAndSubscription	213000	usd
CY2022Q3	gnss	Prepaid Professional Services PrepaidProfessionalServices	0	usd
CY2021Q3	gnss	Prepaid Professional Services PrepaidProfessionalServices	158000	usd
CY2022Q3	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	228000	usd
CY2021Q3	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	2255000	usd
CY2022Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3003000	usd
CY2021Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3726000	usd
CY2022Q3	gnss	Accrued Contract Costs AccruedContractCosts	809000	usd
CY2021Q3	gnss	Accrued Contract Costs AccruedContractCosts	416000	usd
CY2022Q3	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	159000	usd
CY2021Q3	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	146000	usd
CY2022Q3	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	1556000	usd
CY2021Q3	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	0	usd
CY2022Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	5000	usd
CY2021Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2000	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	12083000	usd
CY2021Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	14111000	usd
CY2022Q3	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	680000	usd
CY2021Q3	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	687000	usd
CY2022Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	907000	usd
CY2021Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	995000	usd
CY2021Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	146000	usd
CY2020Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	126000	usd
CY2022	gnss	Product Warranty Accrual Increase Decrease For New Warranties Issuance And Adjustment Preexisting Warranties ProductWarrantyAccrualIncreaseDecreaseForNewWarrantiesIssuanceAndAdjustmentPreexistingWarranties	86000	usd
CY2021	gnss	Product Warranty Accrual Increase Decrease For New Warranties Issuance And Adjustment Preexisting Warranties ProductWarrantyAccrualIncreaseDecreaseForNewWarrantiesIssuanceAndAdjustmentPreexistingWarranties	56000	usd
CY2022	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	73000	usd
CY2021	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	36000	usd
CY2022Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	159000	usd
CY2021Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	146000	usd
CY2021Q3	us-gaap	Long Term Debt LongTermDebt	296000	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	277000	usd
CY2022	gnss	Longterm Debt Currency Translation LongtermDebtCurrencyTranslation	19000	usd
CY2022Q3	us-gaap	Long Term Debt LongTermDebt	0	usd
CY2022	gnss	Increase In Lease Liability With10 Increase In Index IncreaseInLeaseLiabilityWith10IncreaseInIndex	42000	usd
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4862000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	466000	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	746000	usd
CY2022	gnss	Effect Of Exchange Rate On Operating Lease Rou Assets EffectOfExchangeRateOnOperatingLeaseROUAssets	-41000	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4541000	usd
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	6608000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	466000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	894000	usd
CY2022	gnss	Effect Of Exchange Rate On Operating Lease Liability EffectOfExchangeRateOnOperatingLeaseLiability	-43000	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	6137000	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5189000	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	948000	usd
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y8M12D
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.041	pure
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	239000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1065000	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	435000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1179000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1177000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1154000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1169000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1191000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	1038000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	6908000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	771000	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	6137000	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	1002000	usd
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	991000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	3000	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1000	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	70000	usd
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	73000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	568000	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	368000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	100000	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	65000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	668000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	433000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	741000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	434000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-3314000	usd
CY2022	gnss	Nondeductible Compensation Interest Expense And Other NondeductibleCompensationInterestExpenseAndOther	4101000	usd
CY2021	gnss	Nondeductible Compensation Interest Expense And Other NondeductibleCompensationInterestExpenseAndOther	57000	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-859000	usd
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	210000	usd
CY2022	gnss	Income Tax Reconciliation Change In Research And Development Carryover IncomeTaxReconciliationChangeInResearchAndDevelopmentCarryover	-186000	usd
CY2021	gnss	Income Tax Reconciliation Change In Research And Development Carryover IncomeTaxReconciliationChangeInResearchAndDevelopmentCarryover	19000	usd
CY2022	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	25000	usd
CY2021	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	-175000	usd
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-1000	usd
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-117000	usd
CY2022	gnss	Income Tax Reconciliation State Business Credit Utilization IncomeTaxReconciliationStateBusinessCreditUtilization	-90000	usd
CY2021	gnss	Income Tax Reconciliation State Business Credit Utilization IncomeTaxReconciliationStateBusinessCreditUtilization	-234000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	741000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	434000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.508	rate
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.485	rate
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.026	rate
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.007	rate
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000	rate
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000	rate
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y2M12D
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y6M
CY2022Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	1620000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	10054000	usd
CY2021Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	11769000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	4712000	usd
CY2021Q3	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	5479000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	688000	usd
CY2021Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	538000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	2331000	usd
CY2021Q3	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	8000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	2245000	usd
CY2021Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	2487000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	280000	usd
CY2021Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	237000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	20310000	usd
CY2021Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	20518000	usd
CY2022Q3	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	313000	usd
CY2021Q3	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	352000	usd
CY2022Q3	gnss	Deferred Tax Liabilities Operating Rightofuse Assets DeferredTaxLiabilitiesOperatingRightofuseAssets	1066000	usd
CY2021Q3	gnss	Deferred Tax Liabilities Operating Rightofuse Assets DeferredTaxLiabilitiesOperatingRightofuseAssets	1222000	usd
CY2022Q3	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	2180000	usd
CY2021Q3	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	2592000	usd
CY2022Q3	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	3559000	usd
CY2021Q3	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	4166000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	9378000	usd
CY2021Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	8313000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	7373000	usd
CY2021Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	8039000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	9378000	usd
CY2022	us-gaap	Increase Decrease In Other Employee Related Liabilities IncreaseDecreaseInOtherEmployeeRelatedLiabilities	1733000	usd
CY2021	us-gaap	Increase Decrease In Other Employee Related Liabilities IncreaseDecreaseInOtherEmployeeRelatedLiabilities	2625000	usd
CY2022	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	324000	usd
CY2021	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	219000	usd
CY2020Q4	us-gaap	Share Price SharePrice	5.98
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	7760639
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1367000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	295000
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	343175
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	4.11
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2745384
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.02
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1367000
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.78
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	26250
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	5.49
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	145235
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.94
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3940899
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.31
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1640310
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.67
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	996000	usd
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	996000	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	996000	usd
CY2022Q3	us-gaap	Share Price SharePrice	2.77
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	491000	usd
CY2022	gnss	Gross Proceeds From Stock Options Exercised GrossProceedsFromStockOptionsExercised	282000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	725000	usd
CY2021	gnss	Gross Proceeds From Stock Options Exercised GrossProceedsFromStockOptionsExercised	210000	usd
CY2022	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	208000	usd
CY2021	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	514000	usd
CY2022Q3	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	3940899
CY2022	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P4Y3M
CY2022Q3	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	3.31
CY2022Q3	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	1640310
CY2022Q3	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	2.67
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1243692
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2227000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1424000	usd
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	145235
CY2022	gnss	Gross Proceeds From Stock Options Exercised GrossProceedsFromStockOptionsExercised	282000	usd
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	104796
CY2021	gnss	Gross Proceeds From Stock Options Exercised GrossProceedsFromStockOptionsExercised	210000	usd
CY2021	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	228633
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-16212000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	704000	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.44
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.44
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2022	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	36495012
CY2021	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	34409478
CY2022	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0
CY2021	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	1179670
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	36495012
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	35589148
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4423202
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	54035000	usd
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	47003000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-15531000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	1084000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2556000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1597000	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	13162000	usd
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	741000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	434000	usd
CY2022Q3	us-gaap	Noncurrent Assets NoncurrentAssets	12262000	usd
CY2021Q3	us-gaap	Noncurrent Assets NoncurrentAssets	14559000	usd
CY2022Q3	us-gaap	Assets Assets	71854000	usd
CY2021Q3	us-gaap	Assets Assets	90128000	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	54035000	usd
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	47003000	usd
CY2022Q3	us-gaap	Noncurrent Assets NoncurrentAssets	12262000	usd
CY2021Q3	us-gaap	Noncurrent Assets NoncurrentAssets	14559000	usd

Files In Submission

Name	View Source	Status
0001437749-22-029275-index-headers.html	Edgar Link	pending
0001437749-22-029275-index.html	Edgar Link	pending
0001437749-22-029275.txt	Edgar Link	pending
0001437749-22-029275-xbrl.zip	Edgar Link	pending
ex_452172.htm	Edgar Link	pending
ex_452173.htm	Edgar Link	pending
ex_452174.htm	Edgar Link	pending
ex_452175.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
gnss-20220930.xsd	Edgar Link	pending
gnss20220930_10k.htm	Edgar Link	pending
gnss20220930_10kimg001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
gnss-20220930_def.xml	Edgar Link	unprocessable
gnss-20220930_pre.xml	Edgar Link	unprocessable
gnss20220930_10k_htm.xml	Edgar Link	completed
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
gnss-20220930_cal.xml	Edgar Link	unprocessable
gnss-20220930_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GNSS
Genasys Inc. Stock $gnss

2022 Q4 Form 10-K Financial Statement

#000143774922029275 Filed on December 16, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GNSS Genasys Inc. Stock $gnss

2022 Q4 Form 10-K Financial Statement

#000143774922029275 Filed on December 16, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GNSS
Genasys Inc. Stock $gnss